Last reviewed · How we verify
Observational, Retrospective Analysis to Evaluate Switching to Raltegravir Plus Abacavir/Lamivudine in HIV-1-Infected Patients. ORASWIRAL Study
RESEARCH METHODS Study Design Observational, Retrospective, Single-center, Single-arm Study of patients treated with raltegravir plus abacavir and lamivudine.
Details
| Lead sponsor | IRCCS San Raffaele |
|---|---|
| Status | COMPLETED |
| Enrolment | 100 |
| Start date | 2016-04 |
| Completion | 2016-12 |
Conditions
- HIV
Primary outcomes
- Durability of an antiretroviral regimen of raltegravir plus abacavir and lamivudine — time to treatment failure through 96 weeks